Revista Brasileira de Ginecologia e Obstetrícia. 2017;39(6):255-257
Polycystic ovarian syndrome (PCOS) significantly impacts women, since the broad spectrum of clinical manifestations associated with it are significant and include reproductive dysfunction, menstrual irregularities, and an increased risk of infertility. However, the consequences of PCOS go beyond the reproductive axis, with psychological and social impairments, including stress, depression, anxiety, and sexual dissatisfaction. There is also a high prevalence of dyslipidemia, hyperinsulinemia, obesity, hypertension, and glucose intolerance, which are risk factors that predispose women to cardiovascular disease (CVD) and diabetes mellitus type 2 (DM2). Therefore, PCOS assumes aspects of a chronic disease, as these factors extend throughout life. If not prevented and treated, they can lead to increased morbidity and mortality. The etiology of PCOS has not been fully elucidated, but it is known to be linked to excess androgens. Insulin resistance (IR) is a common feature of PCOS, and although it is not considered a diagnostic criterion, it is a key factor in the syndrome’s etiology and evolution.
In 2008, the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) published a consensus suggesting lifestyle changes as the first line of treatment for women with PCOS. This consensus was reinforced in 2009 by The Androgen Excess and Polycystic Ovary Syndrome Society, which investigated evidence of lifestyle management (dietary, exercise, or behavioral interventions) for obesity in women with PCOS. Since then, the benefits of lifestyle changes resulting from PCOS therapy have been well documented. The rationale for this non-pharmacological therapy is based on regular exercise and a healthy diet, as well as combined interventions that aim to achieve and maintain a healthy weight to minimize hormonal and reproductive complications, reduce the long-term risks of chronic diseases such as CVD and DM2, and consequently improve quality of life. In this way, weight loss has been considered the main goal of PCOS therapy in obese women.
[…]
Search
Search in:
Polycystic ovarian syndrome (PCOS) significantly impacts women, since the broad spectrum of clinical manifestations associated with it are significant and include reproductive dysfunction, menstrual irregularities, and an increased risk of infertility. However, the consequences of PCOS go beyond the reproductive axis, with psychological and social impairments, including stress, depression, anxiety, and sexual dissatisfaction. There is also a high prevalence of dyslipidemia, hyperinsulinemia, obesity, hypertension, and glucose intolerance, which are risk factors that predispose women to cardiovascular disease (CVD) and diabetes mellitus type 2 (DM2). Therefore, PCOS assumes aspects of a chronic disease, as these factors extend throughout life. If not prevented and treated, they can lead to increased morbidity and mortality. The etiology of PCOS has not been fully elucidated, but it is known to be linked to excess androgens. Insulin resistance (IR) is a common feature of PCOS, and although it is not considered a diagnostic criterion, it is a key factor in the syndrome's etiology and evolution.
In 2008, the European Society of Human Reproduction and Embryology (ESHRE) and the American Society for Reproductive Medicine (ASRM) published a consensus suggesting lifestyle changes as the first line of treatment for women with PCOS. This consensus was reinforced in 2009 by The Androgen Excess and Polycystic Ovary Syndrome Society, which investigated evidence of lifestyle management (dietary, exercise, or behavioral interventions) for obesity in women with PCOS. Since then, the benefits of lifestyle changes resulting from PCOS therapy have been well documented. The rationale for this non-pharmacological therapy is based on regular exercise and a healthy diet, as well as combined interventions that aim to achieve and maintain a healthy weight to minimize hormonal and reproductive complications, reduce the long-term risks of chronic diseases such as CVD and DM2, and consequently improve quality of life. In this way, weight loss has been considered the main goal of PCOS therapy in obese women.
[...]
Comments